The Family Firm’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.93M Buy
22,381
+955
+4% +$82.2K 0.46% 56
2025
Q1
$1.95M Buy
21,426
+483
+2% +$43.9K 0.44% 51
2024
Q4
$1.8M Buy
20,943
+4,600
+28% +$425K 0.4% 54
2024
Q3
$1.6M Sell
16,343
-227
-1% -$22K 0.35% 61
2024
Q2
$1.54M Buy
16,570
+106
+0.6% +$9.67K 0.34% 57
2024
Q1
$1.53M Sell
16,464
-198
-1% -$17.9K 0.37% 55
2023
Q4
$1.44M Buy
16,662
+35
+0.2% +$2.9K 0.37% 55
2023
Q3
$1.37M Hold
16,627
0.38% 55
2023
Q2
$1.41M Buy
16,627
+14
+0.1% +$1.19K 0.37% 55
2023
Q1
$1.38M Sell
16,613
-439
-3% -$36.4K 0.38% 54
2022
Q4
$1.45M Sell
17,052
-573
-3% -$47.3K 0.42% 51
2022
Q3
$1.33M Sell
17,625
-140
-0.8% -$11.3K 0.42% 47
2022
Q2
$1.44M Buy
17,765
+115
+0.7% +$9.61K 0.42% 48
2022
Q1
$1.55M Sell
17,650
-424
-2% -$35.9K 0.41% 53
2021
Q4
$1.63M Buy
18,074
+549
+3% +$47.4K 0.42% 48
2021
Q3
$1.5M Sell
17,525
-237
-1% -$20.5K 0.39% 52
2021
Q2
$1.48M Buy
17,762
+102
+0.6% +$8.25K 0.4% 49
2021
Q1
$1.36M Buy
17,660
+322
+2% +$24.8K 0.39% 53
2020
Q4
$1.36M Buy
17,338
+370
+2% +$27.2K 0.4% 51
2020
Q3
$1.22M Buy
16,968
+505
+3% +$36.2K 0.44% 46
2020
Q2
$1.13M Buy
16,463
+348
+2% +$23.5K 0.42% 48
2020
Q1
$982K Sell
16,115
-1,614
-9% -$106K 0.42% 49
2019
Q4
$1.22M Buy
17,729
+103
+0.6% +$6.68K 0.41% 53
2019
Q3
$1.08M Buy
17,626
+192
+1% +$11.7K 0.38% 54
2019
Q2
$1.08M Buy
17,434
+4,017
+30% +$241K 0.38% 54
2019
Q1
$820K Buy
13,417
+442
+3% +$26.3K 0.3% 59
2018
Q4
$735K Buy
12,975
+65
+0.5% +$3.89K 0.29% 58
2018
Q3
$813K Hold
12,910
0.29% 60
2018
Q2
$729K Sell
12,910
-1,432
-10% -$80.8K 0.27% 57
2018
Q1
$798K Hold
14,342
0.31% 55
2017
Q4
$807K Buy
14,342
+66
+0.5% +$3.71K 0.32% 55
2017
Q3
$803K Sell
14,276
-298
-2% -$16.4K 0.34% 54
2017
Q2
$797K Buy
14,574
+104
+0.7% +$5.53K 0.35% 53
2017
Q1
$744K Sell
14,470
-778
-5% -$38.9K 0.35% 48
2016
Q4
$723K Buy
15,248
+1,966
+15% +$94.3K 0.34% 53
2016
Q3
$669K Sell
13,282
-206
-2% -$10.6K 0.32% 53
2016
Q2
$681K Sell
13,488
-548
-4% -$27.3K 0.34% 50
2016
Q1
$676K Buy
14,036
+24
+0.2% +$1.15K 0.34% 53
2015
Q4
$719K Sell
14,012
-1,192
-8% -$61.3K 0.38% 49
2015
Q3
$749K Buy
15,204
+88
+0.6% +$4.75K 0.41% 45
2015
Q2
$822K Sell
15,116
-200
-1% -$11K 0.42% 40
2015
Q1
$826K Sell
15,316
-800
-5% -$41.9K 0.42% 41
2014
Q4
$802K Buy
+16,116
New +$801K 0.42% 40

Other funds holding IXJ

The Family Firm's IXJ Position: Q2 2025 in Review

The Family Firm increased its iShares Global Healthcare ETF (IXJ) stake by 4.5% in Q2 2025, buying an estimated $82.2K and bringing the position to 22,381 shares worth $1.93M. The position accounts for 0.46% of the portfolio, ranked #56.

The Family Firm first reported a position in IXJ in Q4 2014 and has held it in 43 quarters since. The position peaked at $1.95M in Q1 2025. 268 funds tracked by Wall St. Rank hold IXJ as of Q2 2025.

  • The Family Firm held 22,381 shares of iShares Global Healthcare ETF worth $1.93M as of Q2 2025.
  • The Family Firm bought 955 iShares Global Healthcare ETF shares in Q2 2025, an estimated $82.2K.
  • iShares Global Healthcare ETF made up 0.46% of The Family Firm's portfolio in Q2 2025, its #56 holding.
  • The Family Firm first reported a position in iShares Global Healthcare ETF in Q4 2014 and has held it in 43 quarters since.
  • The Family Firm's iShares Global Healthcare ETF position peaked at $1.95M in Q1 2025.
  • 268 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.